Glycobond Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $59.1K

  • Investors
  • 7

Glycobond General Information

Description

Developer of carbohydrate-binding peptides designed to diagnose and monitor liver diseases and cancer. The company's peptides are developed using recombinant technology with defined specificities to detect aberrant and cancer-specific glycosylation, an acute-phase plasma protein produced mainly in the liver, enabling physicians to diagnose primary liver diseases and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Diagnostic Equipment
Corporate Office
  • Teknikringen 1F
  • 583 30 Linkoping
  • Sweden
+46 072-546 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycobond Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 15-Dec-2017 $59.1K Completed Generating Revenue
4. Later Stage VC 11-Apr-2017 Completed Generating Revenue
3. Later Stage VC 08-Nov-2016 Completed Generating Revenue
2. Early Stage VC 08-Apr-2015 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view Glycobond’s complete valuation and funding history, request access »

Glycobond Patents

Glycobond Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200319189-A1 Diagnostic test for hepatocellular carcinoma Active 09-May-2016 000000000
JP-6189499-B1 Novel binding assay Active 09-May-2016 000000000000
JP-2017203762-A Novel binding assay Active 09-May-2016 000000000000 0
US-11467162-B2 Diagnostic test for hepatocellular carcinoma Active 09-May-2016 000000000 0
EP-3455634-A2 Novel binding assay Pending 09-May-2016 G01N33/68
To view Glycobond’s complete patent history, request access »

Glycobond Executive Team (2)

Name Title Board Seat Contact Info
Peter Påhlsson Ph.D Co-Founder, Chief Executive Officer & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Glycobond Board Members (4)

Name Representing Role Since
Bengt-Harald Jonsson Ph.D Glycobond Board Member 000 0000
Ingvar Rydén Ph.D Self Board Member 000 0000
Peter Påhlsson Ph.D Glycobond Co-Founder, Chief Executive Officer & Board Member 000 0000
Stefan Eschbach Ph.D Self Chairman of the Board 000 0000
To view Glycobond’s complete board members history, request access »

Glycobond Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycobond Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
LiU Invest Venture Capital Minority 000 0000 000000 0
Almi Invest Venture Capital Minority 000 0000 000000 0
Håkan Englund Angel (individual) Minority 000 0000 000000 0
Santiago Pulido Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »